Exidavnemab phase 2a study expanded to include MSA patients
Stock Titan - 08 May 2025Exidavnemab phase 2a study expanded to include MSA patients ...
phase 2a
Exidavnemab phase 2a study expanded to include MSA patients ...
Exidavnemab phase 2a study expanded to include MSA patients
TradingView - 08 May 2025Exidavnemab phase 2a study expanded to include MSA patients ...
GRI Bio reports interim biomarker data from Phase 2a study of GRI-0621
TipRanks - 08 May 2025GRI Bio reports interim biomarker data from Phase 2a study of GRI-0621 ...
Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease
BioSpace - 08 May 2025Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease ...
Zetagen Therapeutics Announces Successful Completion of Enrollment in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer
Business Wire - 06 May 2025Zetagen Therapeutics Announces Successful Completion of Enrollment in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer ...
EBX-102-02, A Full-Spectrum Microbiome Drug, Shows Promise for IBS-C in Phase 2a Trial
HCPLive - 06 May 2025EBX-102-02, A Full-Spectrum Microbiome Drug, Shows Promise for IBS-C in Phase 2a Trial ...
Topas Therapeutics’ TPM502 Achieves Gluten-specific
GlobeNewswire - 06 May 2025Topas Therapeutics’ TPM502 Achieves Gluten-specific ...
GRI Bio's Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF”)
The Manila Times - 08 May 2025GRI Bio's Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF”) ...
Panama City reaches milestone in Harrison Avenue Streetscape Project. Part of road reopens
Panama City News Herald - 05 May 2025Panama City reaches milestone in Harrison Avenue Streetscape Project. Part of road reopens ...
GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
Stock Titan - 08 May 2025GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) ...
GRI Bio announces enrollment update for Phase 2a study of GRI-0621
TipRanks - 08 May 2025GRI Bio announces enrollment update for Phase 2a study of GRI-0621 ...
Mumbai Metro Line 3 Phase 2A to be open to public on May 10
CNBC TV18 - 08 May 2025Mumbai Metro Line 3 Phase 2A to be open to public on May 10 ...
Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
PR Newswire - 10 Mar 2025Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough ...
Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress
BioSpace - 07 May 2025Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress ...
Inmagene Reports Topline Results from Phase 2a Study of
GlobeNewswire - 24 Apr 2025Inmagene Reports Topline Results from Phase 2a Study of ...
Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update
The Manila Times - 08 May 2025Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update ...
GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
Stock Titan - 07 May 2025GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”) ...
Lipella Reports Positive Phase 2a Results from Second
GlobeNewswire - 22 Apr 2025Lipella Reports Positive Phase 2a Results from Second ...
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
GlobeNewswire - 08 Apr 2025Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus ...